|
|---|
Category:Memoranda
MONTHYEARML22258A3132022-09-27027 September 2022
Meeting Summary to Discuss Draft Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility
ML22258A3102022-09-27027 September 2022
Input for ACRS Review of Shine Operating License Application - Safety Evaluation Report for Chapter 12, Conduct of Operations (Operator Training and Requalification, and Startup Plan)
ML22258A3082022-09-26026 September 2022
Input for ACRS Review of Shine Operating License Application - Safety Evaluation Report for Chapter 3, Design of Structures, Systems, and Components
ML22258A3052022-09-26026 September 2022
Input for ACRS Review of Shine Operating License Application - Safety Evaluation Report for Chapter 7, Instruments and Control Systems, Section 7.4.9, Human Factors Engineering
ML22258A3072022-09-23023 September 2022
Input for ACRS Review of Shine Operating License Application - Safety Evaluation Report for Chapter 9, Auxiliary Systems, Section 9A.2.3, Fire Protection Systems and Programs
ML22216A1122022-08-0808 August 2022
Shine Technologies LLC - Regulatory Audit Plan of Logic Lifecycle Described in Operating License
ML21019A1592021-01-27027 January 2021
Public Meeting Summary January 12 2021
ML20010D1692020-01-16016 January 2020
Memo to R. Elliott from J. Davis Summary of Public Scoping Meeting Conducted for the Shine Medical Technologies, LLC Operating License Application Review (Docket 50-608)w/Enclosures 1 and 2
ML14139A5412014-05-22022 May 2014
Shine Medical Technologies, Inc. - Memo to Adm Regarding Correction to the Federal Register Notice Related to the Acceptance for Docketing of Part Two of the Application for Construction Permit
ML14063A5882014-03-0606 March 2014
& 03/20/2014 - Notice of Forthcoming Public Meeting with Shine Medical Technologies, Inc to Discuss Topics Associated with Design Changes Related to the Proposed Shine Facility and Preliminary Safety Analysis Report
ML13227A3912013-09-23023 September 2013
Summary of Public Meetings Conducted Related to the Review of the Proposed Shine Radioisotope Production Facility
ML13178A3142013-07-0303 July 2013
7/17/13- Notice of Forthcoming Category 3 Public Meetings with Shine Medical Technologies, Inc. on the Environmental Scoping Process
2022-09-27
[Table view] |
Text
May 22, 2014 MEMORANDUM TO: Cindy K. Bladey, Chief Rules, Announcements, and Directives Branch Division of Administrative Services Office of Administration FROM: Steven T. Lynch, Project Manager /RA/
Research and Test Reactors Licensing Branch Division of Policy and Rulemaking Office of Nuclear Reactor Regulation
SUBJECT:
SHINE MEDICAL TECHNOLOGIES, INC. - CORRECTION TO FEDERAL REGISTER NOTICE RELATED TO THE ACCEPTANCE FOR DOCKETING OF PART TWO OF THE APPLICATION FOR CONSTRUCTION PERMIT (NRC-2013-0053)
Enclosed please find one copy of the subject Federal Register notice for transmittal to the Office of the Federal Register for publication.
ADM/DAS/RDB has been given owners rights to the Federal Register notice, which is available in the Agencywide Documents Access and Management System (ADAMS) under Accession No. ML14139A544. Publicly available U.S. Nuclear Regulatory Commission documents referenced in the notice have been finalized in ADAMS and profiled for public release. The ADAMS accession numbers for all such documents are provided in the text of the notice.
Docket No. 50-608
Enclosure:
As stated CONTACT: Steven T. Lynch, NRR/DPR 301-415-1524
(Pkg.) ML14139A545; (FRN) ML14139A544; (Memo) ML14139A541 ADM-012 OFFICE NRR/DPR/PRLB/PM NRR/DPR/PRLB/LA NRR/DPR/PRLB/BC NRR/DPR/PRLB/PM NAME SLynch PBlechman AAdams SLynch DATE 05/21/2014 05/21/2014 05/21/2014 05/22/2014